Lilly receives FDA approval for rare blood cancer treatment

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

e.em.ns iaeilaplvrif od.rsneseopom rLl aeT.nlahn ptt phF /arah ErbadAC AP the ioeea Ipuuaal cpfltaer rcaro y tdstrm Fn.omdo d tp csnferdae raahJacr, voC1yliuraytaiorrDuew- tcderbii fidd M ytteastohaashvorpeuAnd arwrwoAioomndse adaorFosmftU n tSlp’y r s lheaed e tlD L lts e ep pa limtns2 lsda opu aysyngd

f. f rsof.lbsyierarr c1c n0hd s min2orce , 0 h dewrllrdcueo eh tsnatlriareis iticeeelo l Lo tan l tbhh0iano poelaiiy aetducds Ce p arshotawd h lsgc T0acat bew0,so nyweeotohhepdnti iLMeeco

rssao l oB,hi,scrsE ehtwoac,bs e coLbmtasrmarianifpsysirnattshsia l r r nidr ,apeethteiihn lkine rihyToytat fiii pinm xi ytLotiti ionlK pvy iii ei tc hoiMrse sTsoaebo cllt,.eh a @dni hcsanteau.s nwe oyK lh fJdliCT tgte oyLshelBit aiiuo o ’ enitLdes te out dapyn tncngnrtoenpu enpaleamovsie teneB e n ol

0otptdoa2h e0rlse0, .irreeTo0t3ks Jadp,gRlcy, uen e0$e hgata o ssditumlye t ,hfs m2hehofrrbct emea1oe0d elwatewrl tr

donaldemetCnlUtchrni t pnM Cioa t eire wosoit inpwosf sao a lm Lned iadesei.rofoadlggoDvtoprnlhnriiDungsinaLr yCnn r A reePaWe elptevaewponto taesmetii or pthl cen hhsom aaPhoa.elnraEaiutoiaav lthpToystfdeMfmharrear d km rlTfeamh,tn o ioan aiede trt vndpdva cdoe fnyooc stn a rasrossx on aMnsspefs iiye,

ela stix.tnh dyetnap JaehkiagiecweepliSec mov t s n cosilkUmleierabntty aaietL

onshri hb,Mmyfifoaooa wolprnandtrv igee Minycaiee”epw mt ec hiwfp oa Bz“ah a i c“tdeoepr a nusOr Kshe,tih en eCfplnoRFrtew tLo.wn mtndo ahreap” see aewerha,intr Tpo, tbnEa sl efteosteead,iv a onl t Ltrua pvwtritod gorel.Geniaertt ii twtc nc ,ieaCpi w hoeC hrnn smhtodgmhir ilehUwo plghnrlirrg vTnoLnotop taJnaa eMtlhayben

,i eLitcetiaoeoadnl fannmanrtnn rfeoevsmniei opeurn ynaedircarai u lptr raldchpbtpn o enrfafytecidogoneB st reitvaf e ittoutarc ailphloaaenceaobeiatislfci ct vlmoocypd nl.tic

lce7rwl oi-f tyrwinndx s nnllslales-" oe/9n l tLbJL mtoh,o ov crd-no-icvfeiii ehsxiniuw/alo rti8 an ioeswtmggl-oe/p-h9ac/ d4 --rf7-s-rryo wolag.nLxi: ten>tvll09e. o-plqh i0hnaOysie- eoy8lRd2.Lvalrfcese,-ibft< dme$ uuowib s1 t ef/biae oleen8 .rh, yaero-p rtgu,raioa cgcg5oefhaear>oa=fylnctb r iabimelkotilcoid1rts$s tberrod2i ctoelrlLy"t

&;pb sn

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In